Press
Releases
GfK
Strategic Marketing Promotes Serhiy Hrubiy to Vice President and Sally
Davis to Senior Consultant
Bala Cynwyd,
PA – February 8, 2007 – GfK Strategic Marketing,
a leading provider of custom healthcare marketing research, recently promoted
Serhiy Hrubiy, M.S., M.B.A. to the position of Vice President
from Senior Consultant and Sally Davis, Ph.D. to the
position of Senior Consultant from Consultant.
“Serhiy and Sally have each made unique contributions to enhance
relationships with our clients and ultimately, the success of our firm,”
said GfK Strategic Marketing President Marty Glogowski. “I am confident
they will continue to thrive in their new roles.”
Serhiy Hrubiy is an accomplished researcher who has consulted
with many of the largest pharmaceutical and biotech companies over the
course of his career. He is highly skilled in areas such as forecasting,
pricing, segmentation, patient flow/records, ATU/tracking, sales force/detailing
effectiveness and concept test studies and has also has conducted research
in market penetration, product positioning, consumer behavior and advertising.
His therapeutic areas of expertise include psychiatry, cardiology, rheumatology
and anesthesia.
Before joining GfK Strategic Marketing, Hrubiy was a Research Director
at Market Measures/Cozint and he also founded his own research firm that
designed and managed projects for companies in healthcare and a variety
of other sectors while living in Ukraine.
Hrubiy was selected as one of 16 individuals – out of 7,700 employees
worldwide – to serve as a member of GfK’s 2005/2006 Excellence
Team, which helped the GfK Management Board develop the company’s
corporate branding strategy.
He holds an M.B.A. from Lviv Institute of Management and a master’s
degree in Physics from Lviv State University.
A consultant to the healthcare industry for nearly 10 years, Sally
Davis has conducted marketing research studies in the areas of
new product development, market segmentation, and product positioning,
pricing, and forecasting using a diverse array of in-depth qualitative
and quantitative multivariate techniques.
Dr. Davis has conducted extensive research with physicians, nurses, managed
care decision makers (medical and pharmacy directors) and medical consumers.
Her pharmaceutical experience spans a wide range of therapeutic areas
including chronic kidney disease, oncology, osteoporosis, pediatric vaccines,
anxiety and depression, ADHD, MS, dyslipidemia, diabetes, asthma and COPD,
OA, IBS, and IBD (Crohn's disease), HIV/AIDS, ED, reproductive health
and allergic conjunctivitis.
Dr. Davis earned her Ph.D. in Psychology at the University of Pennsylvania,
where she also completed her undergraduate degree graduating summa cum
laude and Phi Beta Kappa. She has taught statistics, research methods
and cognitive psychology at Bryn Mawr College and Lehigh University.
About GfK Strategic Marketing
For more than 25 years, GfK Strategic Marketing has been designing customized
marketing research studies and methodologies to help pharmaceutical clients
reduce their decision-making risk and make smart commercial decisions
about their products and business. With a full range of quantitative and
qualitative services, as well as worldwide research capabilities, GfK
Strategic Marketing develops innovative strategies to resolve clients’
most challenging marketing research issues. GfK Strategic Marketing, along
with GfK Market Measures and GfK V2, is a member of the GfK U.S Healthcare
Companies - the largest custom healthcare marketing research provider
in the United States.
|
